Innervace
Philadelphia
About Innervace
Innervace is a developer of a regenerative therapy company designed to develop implantable tissue-engineered brain pathways for neurodegenerative disorders. The company is focused on the development and commercialization of anatomically inspired living scaffolds for brain pathway reconstruction, and its lead clinical product is a tissue-engineered nigrostriatal pathway that mimics the lost nigrostriatal pathway in patients with Parkinson's disease. This gives patients access to technology that specifically reconstructs brain pathways rather than just masking symptoms temporarily. Innervace was established in 2018 by in Philadelphia, Pennsylvania
Company Facts
- Operating status: Active
- Company type: Non-Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2022)
- Website: innervace.com
Industries & Categories
Biotechnology, Health Care, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/innervace-11430 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.